RESEARCH TRIANGLE PARK – StrideBio is expanding its manufacturing, office, and lab facilities, and continues to hire, with plans to double the number of employees in RTP to 200 people during the next 12 months, the company told WRAL TechWire today.

The company, which is a developer of adeno-associated viral based (AAV-based) gene therapies, announced in a statement that it has completed a 6,700 square-foot manufacturing facility and added a 15,000 square foot expansion of laboratory and office space as well.

And, the company noted that its workforce has increased to 100 employees, from 70 workers in March.

The company continues to hire, a spokesperson told WRAL TechWire, and plans to double in size within the next year.  Those positions will be based from the company’s new facilities, the spokesperson said.

The company closed an $81.5 million Series B financing round in March 2021, which CEO Sapan Shah, Ph.D., noted in a statement provided the capital to build the team and the company’s infrastructure.

Gene therapy startup StrideBio lands $81.5M in capital, new investors

In total, the StrideBio campus is now 47,000 square feet, the company said.  The expansion will yield “greater capabilities for discovery, GMP production, warehousing, and development of products enabled by novel engineered AAV capsids,” the company said.

“Combined with our wholly-owned proprietary cell-line, manufacturing process and on-site capability, which are optimized for the novel capsids resulting from our STRIVE™ platform, we now have the flexibility to scale and support translation and clinical development of differentiated gene therapies,” said Shah.

The campus now includes:

  • The 28,000 square-foot laboratory space supporting all of the company’s research functions
  • The 6,700 square-foot GMP manufacturing facility, and
  • 12,000 square feet of corporate office space

The company was founded in 2015.  It raised $15.7 million in capital in an oversubscribed fundraising round in 2018.  The company has 18 open positions currently listed on its careers website.

NC’s 3 ‘Engines of Innovation’ – talent, investment, expansion – driving life science industry’s boom